DEKA Loop— 510(k) K234055

Name: FDA 510(k) clearance K234055
Creator: U.S. Food and Drug Administration
Published: 2024-03-13

Substantially Equivalent

Deka Research and Development

FDA 510(k) clearance K234055 for DEKA Loop, Substantially Equivalent on 2024-03-13. Applicant: Deka Research and Development. Device class: 2.

Clearance details

Applicant: Deka Research and Development
Product code: Code QJI
Device class: Class 2
Regulation: 21 CFR 862.1356
Advisory panel: Clinical Chemistry
Date received: 2023-12-22
Decision date: 2024-03-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Manchester, NH, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code QJI

view all

K262763 — iLet Dosing Decision Software2026-09-11
K261962 — SmartGuard Technology; Predictive Low Glucose Technology2026-07-09
K261461 — Omnipod 6 algorithm2026-06-29
K260429 — Control-IQ+ technology2026-04-24
K253701 — SmartGuard Technology; Predictive Low Glucose Technology2026-02-03

More clearances from Deka Research and Development

view all

K261672 — twiist Automated Insulin Delivery (AID) System2026-06-17
K261530 — iiSure Infusion Set2026-06-03
K243841 — Sparta Infusion Set for Insulin2025-08-01
K233557 — HemoCare Hemodialysis System2024-07-12
K240920 — HemoCare Bicarbonate Concentrate Set (BCS)2024-07-12

Adverse events under product code QJI

product code QJI

Other: 3
Total: 3

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.